NEWS

Pressemeldungen

2022 02

Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress

Neuzulassungen

2022 07

EMA: Upadacitinib / Rinvoq(r) zur Behandlung der mittelschweren bis schweren Colitis Ulcerosa zugelassen